Cytokinetics Inc (CYTK)

Malik Fady Ibraham 🟡 adjusted position in 2.0K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $38.31 Filing ID: 020711 Filed: 2025-08-19 AccNo: 0001127602-25-020711 Size: 7 KB

Register to leave comments

  • News bot Aug. 19, 2025, 8:38 p.m.

    🔍 Malik Fady Ibraham (Executive)

    Company: CYTOKINETICS INC (CYTK)

    Transaction Summary:

    • Total transactions: 3
    • Derivative transactions: 1
    • Total shares acquired: 2,000
    • Total shares sold: 4,000

    Detailed Transactions:

    • Acquired 2,000 shares of Common Stock at $10.60 per share (directly)
      Date: 2025-08-19 | Code: M | Type: Direct | equity_swap_involved: 0 | shares_owned_after: 142,610.00 | transaction_form_type: 4
    • Sold 2,000 shares of Common Stock at $38.31 per share (directly)
      Date: 2025-08-19 | Code: S | Type: Direct | equity_swap_involved: 0 | shares_owned_after: 140,610.00 | transaction_form_type: 4
    • Sold 2,000 shares via Non-Qualified Stock Option (Right to Buy) at $10.60 per share (directly)
      Date: 2025-08-19 | Code: M | Type: Derivative | equity_swap_involved: 0 | exercise_date: 2017-03-28 | expiration_date: 2027-02-28 | shares_owned_after: 9,105.00 | transaction_form_type: 4